Riku Katainen

4.0k total citations · 1 hit paper
33 papers, 1.6k citations indexed

About

Riku Katainen is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Riku Katainen has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Pathology and Forensic Medicine and 10 papers in Cancer Research. Recurrent topics in Riku Katainen's work include Genetic factors in colorectal cancer (11 papers), Cancer Genomics and Diagnostics (9 papers) and Colorectal Cancer Treatments and Studies (5 papers). Riku Katainen is often cited by papers focused on Genetic factors in colorectal cancer (11 papers), Cancer Genomics and Diagnostics (9 papers) and Colorectal Cancer Treatments and Studies (5 papers). Riku Katainen collaborates with scholars based in Finland, Sweden and Denmark. Riku Katainen's co-authors include Lauri A. Aaltonen, Eevi Kaasinen, Pia Vahteristo, Miika Mehine, Netta Mäkinen, Esa Pitkänen, Jari Sjöberg, Minna Taipale, Massimiliano Gentile and Jussi Taipale and has published in prestigious journals such as Science, New England Journal of Medicine and Nature Medicine.

In The Last Decade

Riku Katainen

32 papers receiving 1.6k citations

Hit Papers

MED12 , the Mediator Complex Subunit 12 Gene, Is Mutated ... 2011 2026 2016 2021 2011 100 200 300 400

Peers

Riku Katainen
Riku Katainen
Citations per year, relative to Riku Katainen Riku Katainen (= 1×) peers Eiichiro Tominaga

Countries citing papers authored by Riku Katainen

Since Specialization
Citations

This map shows the geographic impact of Riku Katainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riku Katainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riku Katainen more than expected).

Fields of papers citing papers by Riku Katainen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riku Katainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riku Katainen. The network helps show where Riku Katainen may publish in the future.

Co-authorship network of co-authors of Riku Katainen

This figure shows the co-authorship network connecting the top 25 collaborators of Riku Katainen. A scholar is included among the top collaborators of Riku Katainen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riku Katainen. Riku Katainen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taira, Aurora, Mervi Aavikko, Riku Katainen, et al.. (2025). Comprehensive metabolomic and epigenomic characterization of microsatellite stable BRAF-mutated colorectal cancer. Oncogene. 44(22). 1718–1730. 2 indexed citations
2.
Katainen, Riku, Jun Dai, Anna Vähärautio, et al.. (2025). Drug-tolerant persisting polyploid giant cancer cells mediate resistance to HER2-targeting antibody-drug conjugates. Cancer Letters. 630. 217900–217900. 2 indexed citations
3.
Afyounian, Ebrahim, Riku Katainen, Anssi Nurminen, et al.. (2024). Previously reported CCDC26 risk variant and novel germline variants in GALNT13, AR, and MYO10 associated with familial glioma in Finland. Scientific Reports. 14(1). 11562–11562. 1 indexed citations
4.
Berger, Hilmar, Federica Battistini, Britta A. M. Bouwman, et al.. (2020). Colibactin DNA-damage signature indicates mutational impact in colorectal cancer. Nature Medicine. 26(7). 1063–1069. 188 indexed citations
5.
Hänninen, Ulrika A., Erkki‐Ville Wirta, Riku Katainen, et al.. (2019). Exome and immune cell score analyses reveal great variation within synchronous primary colorectal cancers. British Journal of Cancer. 120(9). 922–930. 4 indexed citations
6.
Katainen, Riku, Iikki Donner, Tatiana Cajuso, et al.. (2018). Discovery of potential causative mutations in human coding and noncoding genome with the interactive software BasePlayer. Nature Protocols. 13(11). 2580–2600. 29 indexed citations
7.
Hänninen, Ulrika A., Riku Katainen, Tomas Tanskanen, et al.. (2018). Exome-wide somatic mutation characterization of small bowel adenocarcinoma. PLoS Genetics. 14(3). e1007200–e1007200. 54 indexed citations
8.
Donner, Iikki, et al.. (2018). Germline mutations in young non-smoking women with lung adenocarcinoma. Lung Cancer. 122. 76–82. 33 indexed citations
9.
Donner, Iikki, Riku Katainen, Eevi Kaasinen, et al.. (2018). Candidate susceptibility variants in angioimmunoblastic T-cell lymphoma. Familial Cancer. 18(1). 113–119. 11 indexed citations
10.
Kondelin, Johanna, Alexandra E. Gylfe, Tomas Tanskanen, et al.. (2017). Comprehensive Evaluation of Protein Coding Mononucleotide Microsatellites in Microsatellite-Unstable Colorectal Cancer. Cancer Research. 77(15). 4078–4088. 14 indexed citations
11.
Cajuso, Tatiana, Riku Katainen, Päivi Sulo, et al.. (2017). Detection of subclonal L1 transductions in colorectal cancer by long-distance inverse-PCR and Nanopore sequencing. Scientific Reports. 7(1). 14521–14521. 18 indexed citations
12.
Tamene, Fitsum, Helka Göös, Audrey van Drogen, et al.. (2017). Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. Cell Systems. 4(4). 430–444.e5. 63 indexed citations
13.
Mehine, Miika, Hanna-Riikka Heinonen, Nanna Sarvilinna, et al.. (2015). Clonally related uterine leiomyomas are common and display branched tumor evolution. Human Molecular Genetics. 24(15). 4407–4416. 17 indexed citations
14.
Heliövaara, Elina, Anniina Raitila, M-R Rautiainen, et al.. (2014). AIP inactivation leads to pituitary tumorigenesis through defective Gαi-cAMP signaling. Oncogene. 34(9). 1174–1184. 79 indexed citations
15.
Tanskanen, Tomas, Alexandra E. Gylfe, Riku Katainen, et al.. (2014). Systematic search for rare variants in Finnish early-onset colorectal cancer patients. Cancer Genetics. 208(1-2). 35–40. 22 indexed citations
16.
Tuupanen, Sari, Ulrika A. Hänninen, Johanna Kondelin, et al.. (2014). Identification of 33 candidate oncogenes by screening for base-specific mutations. British Journal of Cancer. 111(8). 1657–1662. 31 indexed citations
17.
Gylfe, Alexandra E., Riku Katainen, Johanna Kondelin, et al.. (2013). Eleven Candidate Susceptibility Genes for Common Familial Colorectal Cancer. PLoS Genetics. 9(10). e1003876–e1003876. 60 indexed citations
18.
Mehine, Miika, Eevi Kaasinen, Netta Mäkinen, et al.. (2013). Characterization of Uterine Leiomyomas by Whole-Genome Sequencing. New England Journal of Medicine. 369(1). 43–53. 252 indexed citations
19.
Mäkinen, Netta, Miika Mehine, Jaana Tolvanen, et al.. (2011). MED12 , the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas. Science. 334(6053). 252–255. 470 indexed citations breakdown →
20.
Soikkeli, Johanna, Margus Lukk, Pirjo Nummela, et al.. (2007). Systematic search for the best gene expression markers for melanoma micrometastasis detection. The Journal of Pathology. 213(2). 180–189. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026